IMMUNOTEC RESEARCH LTD.

RESEARCHERS
Dr. Gustavo Bounous -- Discoverer of Immunocal®

Educated at the University of Turin and the University of Genoa in his native Italy,
Gustavo Bounous’ distinguished career in medical research began as a Research Fellow
in surgery at the Indiana Medical Center, Indianapolis. In 1963, he moved to Canada and
commenced an academic career that led him to become Professor of Surgery, firstly at
the University of Sherbrooke (1973-1985), then at McGill University (1985-1993).

Dr. Bounous was awarded the 1965 medal of the Royal College of Physicians and
Surgeons of Canada. He pioneered the use of elemental diets in the prophylaxis and
treatment of intestinal lesions associated with shock, intestinal ischemia, radiation, cancer
chemotherapy and Crohn’s disease.

In 1968, he was named Career Investigator of the Medical Research Council, an award that was reconfirmed
until 1993, the year of his retirement from McGill University. In 1978, Dr. Bounous initiated a novel research
program to search for a dietary protein source that would boost the immune system, in conjunction with a
colleague from the McGill University Faculty of Medicine. Studies led to the discovery of an undenatured serum
milk concentrate that sustains normal glutathione levels and promotes immune enhancing activity. Subsequent
identification of the active ingredients present in this protein mixture, brought on in 1993, the production of a
high-quality bioactive material given the name and trademark Immunocal®.

Dr. Patricia Kongshavn -- Co-Discoverer of Immunocal®

Patricia Kongshavn received her Honors Degree in Natural Sciences as a Major Scholar
at Cambridge University, and completed her doctorate in Immunology at McGill University
after immigrating to Canada. She subsequently joined the Faculty of Medicine at McGill
University and held appointments in the Departments of Physiology and Medicine,
becoming Full Professor in 1986. Her research was funded by independent grants to her
from the Medical Research Council of Canada, the National Cancer Institute of Canada
and the National Institutes of Health in the United States.

In the mid-1970’s she began collaboration initiated by Dr Gustavo Bounous to research the influence of various
dietary proteins on immune responsiveness. They published their first paper on this research in 1978 and
continued their collaboration until 1989, during which period they co-authored 14 papers. This work led to the
discovery of an undenatured whey protein concentrate that regulated glutathione levels and promoted immune
enhancing activity. This led ultimately to the production of a high quality bioactive nutraceutical: Immunocal®.

Dr. Wulf Dröge, Ph.D. -- Senior Vice-President, Research &

Development

Dr. Dröge came to Immunotec from his position as Professor, Faculty of Biology at the
University of Heidelberg and Chair of the Department of Immunochem, Deutsches
Krebsforschungszentrum.

Considered one of the leading scientists worldwide in the field of Aging, Dr. Dröge’s
research has focused on Redox regulation and signaling pathways in lymphocytes; the
pathogenesis of HIV infection; the mechanism of disease-related wasting and aging and
action of tumor necrosis factor.

Dr. Dröge heads Immunotec’s Medical Advisory Board, spearheading its initiatives in the areas of immune
system optimization and anti-aging. As Adjunct Professor at McGill University, he also leads Immunotec’s joint
research projects with McGill.